Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 12/20 | 0.71 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.71 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | INPP5B | P32019 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4186085 | 0.84 | INPPL1 (1.00) | INPPL1INPP5ASRCINPP5BCA1 | |
| SCHEMBL4179021 | 0.82 | INPPL1 (0.48) | INPPL1INPP5ASRCINPP5BBACE1 | |
| SCHEMBL4181918 | 0.79 | INPPL1 (0.45) | INPPL1INPP5ASRCINPP5BBACE1 | |
| SCHEMBL29743077 | 0.78 | SRC (0.59) | INPPL1INPP5ASRCINPP5BCA1 | |
| SCHEMBL14176584 | 0.78 | INPPL1 (0.60) | INPPL1INPP5ASRCINPP5BCA1 | |
| SCHEMBL133534 | 0.78 | SRC (0.59) | INPPL1INPP5ASRCINPP5BCA1 | |
| SCHEMBL30340348 | 0.78 | PTGS2 (0.60) | INPPL1INPP5ASRCCA1CA2 | |
| SCHEMBL2193074 | 0.78 | PTGS2 (0.60) | INPPL1INPP5ASRCCA1CA2 | |
| SCHEMBL4166639 | 0.76 | PTGS2 (0.58) | INPPL1INPP5ASRCCA1CA2 | |
| SCHEMBL30340032 | 0.76 | PTGS1 (0.58) | INPPL1INPP5ASRCCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-7205345-B2 | Blend of a styrene resin, phenolic resin and phosphazene compound; heat resistance | POLYPLASTICS CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| US-7169836-B2 | Mixture of a phosphazene compound, polyphenylene ether , styrene resin and organonitrogen compound | POLYPLASTICS CO., LTD (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20050148701-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2005-07-07 | — | — | US | disclosed |
| US-20040147646-A1 | Flame-retardant resin composition | POLYPLASTICS CO., LTD. (JP) | 2004-07-29 | — | — | US | disclosed |